LBF20207PG50: Difference between revisions
No edit summary |
No edit summary |
||
| Line 5: | Line 5: | ||
|LipidMaps=LMFA03010094 | |LipidMaps=LMFA03010094 | ||
|SysName= (5Z, 13E) - (8R,11R,12R,15R) -11,15-dihydroxy-9-oxoprost-5,13-dienoic acid | |SysName= (5Z, 13E) - (8R,11R,12R,15R) -11,15-dihydroxy-9-oxoprost-5,13-dienoic acid | ||
|Common Name=&&15-epi-prostaglandin E_2 acetate, methyl ester | |Common Name=&&15-epi-prostaglandin E_2 acetate, methyl ester[[Reference:Light_RJ:Samuelsson_B:,Eur. J. Biochem.,1972,28,232|{{RelationTable/GetFirstAuthor|Reference:Light_RJ:Samuelsson_B:,Eur. J. Biochem.,1972,28,232}}]]&& | ||
}} | }} | ||
Revision as of 00:00, 12 December 2008
| IDs and Links | |
|---|---|
| LipidBank | XPR8048 |
| LipidMaps | LMFA03010094 |
| CAS | |
| KEGG | {{{KEGG}}} |
| KNApSAcK | {{{KNApSAcK}}} |
| mol | LBF20207PG50 |
| 15-epi-prostaglandin E2acetate, methyl ester Light_RJ et al. | |
|---|---|
| |
| Structural Information | |
| (5Z, 13E) - (8R,11R,12R,15R) -11,15-dihydroxy-9-oxoprost-5,13-dienoic acid | |
| |
| Formula | C20H32O5 |
| Exact Mass | 352.224974134 |
| Average Mass | 352.46508 |
| SMILES | C(CC[C@@H](O)C=C[C@H]([C@H]1CC=CCCCC(O)=O)[C@@H](CC1=O)O)CC |
| Physicochemical Information | |
| Spectral Information | |
| Mass Spectra | |
| UV Spectra | |
| IR Spectra | |
| NMR Spectra | |
| Other Spectra | |
| Chromatograms | |
| Reported Metabolites, References | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
